Cannabis Sativa, Inc. CBDS
We take great care to ensure that the data presented and summarized in this overview for Cannabis Sativa, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in CBDS
Top Purchases
Top Sells
About CBDS
Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; and holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013. Cannabis Sativa, Inc. is based in Mesquite, Nevada.
Insider Transactions at CBDS
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 08
2025
|
David Tobias CEO |
SELL
Open market or private sale
|
Direct |
437,573
-0.71%
|
$0
$0.03 P/Share
|
Jul 07
2025
|
David Tobias CEO |
SELL
Open market or private sale
|
Direct |
200,000
-0.64%
|
$0
$0.03 P/Share
|
Jun 25
2025
|
David Tobias CEO |
SELL
Open market or private sale
|
Direct |
100,000
-0.32%
|
$0
$0.03 P/Share
|
Jun 24
2025
|
David Tobias CEO |
SELL
Open market or private sale
|
Direct |
121,666
-0.19%
|
$0
$0.03 P/Share
|
Jun 23
2025
|
David Tobias CEO |
SELL
Open market or private sale
|
Direct |
100,000
-0.32%
|
$0
$0.03 P/Share
|
Jun 18
2025
|
David Tobias CEO |
SELL
Open market or private sale
|
Direct |
5,000
-0.02%
|
$0
$0.03 P/Share
|
May 30
2025
|
David Tobias CEO |
SELL
Open market or private sale
|
Direct |
110,000
-0.35%
|
$0
$0.03 P/Share
|
May 29
2025
|
David Tobias CEO |
SELL
Open market or private sale
|
Direct |
154,000
-0.25%
|
$0
$0.03 P/Share
|
Apr 23
2025
|
David Tobias CEO |
SELL
Open market or private sale
|
Direct |
200,000
-0.32%
|
-
|
Feb 06
2025
|
David Tobias CEO |
SELL
Open market or private sale
|
Direct |
25,200
-0.08%
|
$0
$0.01 P/Share
|
Jan 23
2025
|
David Tobias CEO |
SELL
Open market or private purchase
|
Direct |
100,000
-0.31%
|
$0
$0.08 P/Share
|
Jan 22
2025
|
David Tobias CEO |
SELL
Open market or private purchase
|
Direct |
100,000
-0.31%
|
$0
$0.08 P/Share
|
Jan 10
2025
|
David Tobias CEO |
SELL
Open market or private purchase
|
Direct |
73,710
-0.23%
|
$0
$0.08 P/Share
|
Nov 22
2024
|
David Tobias CEO |
BUY
Other acquisition or disposition
|
Direct |
17,500,000
+35.38%
|
-
|
Feb 20
2024
|
Robert N. Tankson Iii Director |
SELL
Open market or private purchase
|
Direct |
269,892
-38.02%
|
$0
$0.01 P/Share
|
Feb 12
2024
|
Robert N. Tankson Iii Director |
SELL
Open market or private purchase
|
Direct |
294,745
-29.34%
|
$0
$0.02 P/Share
|
Feb 09
2024
|
Robert N. Tankson Iii Director |
SELL
Open market or private purchase
|
Direct |
102,395
-9.25%
|
$0
$0.02 P/Share
|
Dec 19
2023
|
David Tobias CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,700,000
+30.5%
|
-
|
Dec 14
2023
|
David Tobias CEO |
SELL
Bona fide gift
|
Direct |
500,000
-5.51%
|
-
|
May 04
2023
|
David Tobias CEO |
SELL
Open market or private sale
|
Direct |
11,016
-0.12%
|
$0
$0.04 P/Share
|
Last 12 Months Summary
Other acquisition or disposition | 17.5M shares |
---|
Open market or private purchase | 274K shares |
---|---|
Open market or private sale | 1.45M shares |